You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

This website uses cookies

By continuing to use this website you consent to using cookies. For more information about cookies and how we use them, please see our Privacy Policy.

We've got you covered

Getinge's peripheral stent technology can help you deliver covered stent results where you need it, when you need it.

 

Why choose a covered stent over a bare metal stent?

Recent studies such as COBEST have demonstrated the efficacy of the use of covered stents (CS) vs. bare metal stents (BMS) in the treatment of aorto-iliac occlusive disease. The 5-year results of the COBEST showed that CS has an enduring patency advantage over BMS in both the short and long terms. CS showed significantly higher patency and a survival benefit compared with the BMS in TASC C and D lesion (p=.003). Additionally, fewer patients received target limb revascularization in the CS group than in the BMS group (p=.02).

Atrium Advanta V12 is not available in the U.S.

Learn about the COBEST 5-year results

Why endovascular therapy should be the first line of treatment in patients with severe (TASC II C or D) aortoiliac occlusive disease

Superior outcomes have been reported when using covered stents in aorto-iliac occlusions. Complex long-segment and bilateral iliac occlusions can be safely treated via endovascular means with high rates of symptom resolution. Initial technical success, low morbidity, and mid-term durability are comparable to results with open reconstruction.

Endovascular treatment using primary stenting should be considered as the first line treatment for almost all patients with aorto-iliac occlusive disease.

Read more about a recent study

Choose the covered stent that adapts to fit each patient’s unique anatomy

With its PTFE encapsulation and open cell design, the Atrium Advanta V12 is able to be customized to match each patient's anatomy. V12 provides options for your diverse patient needs.

Atrium Advanta V12 is not available in the U.S.

Learn more about the Advanta V12 balloon-expandable covered stent

Images are a pictorial demonstration and not actual product applications. Post dilation should always be done following the guidelines within the Atrium Advanta V12 IFU.